Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Reporting entity (Details Textual)

v3.23.1
Note 1 - Reporting entity (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jul. 18, 2022
Mar. 31, 2023
Dec. 31, 2022
Notes To Financial Statements [Abstract]      
Accumulated deficit   $ (478,006) $ (464,330)
Cash and investment   35,700 47,000
Working capital   $ 25,500 $ 37,200
Common stock bid price per share $ 1.00    
Closing bid price requirement description   On January 18, 2023, we qualified for a 180-day extension to July 18, 2023. If we are unable to meet the minimum closing bid price requirement under Nasdaq Listing Rule 5810(c)(3)(A) by then, Nasdaq will provide notice that our securities will be subject to delisting. In order to regain compliance with such rule, we are considering a reverse stock split of the Company’s outstanding Common Shares at a ratio in the range of 1-for-10 to 1-for-20 (the Reverse Stock Split”). The Reverse Stock Split is conditional upon the approval of the shareholders of the Company at the annual and special meeting of shareholders to be held on May 23, 2023 and upon the approval of the Board of Directors of the Company which, if it determines to proceed with the Reverse Stock Split, will also determine its exact ratio and date.